tbuckley/cabot-search huggingface dataset:
American Alkalometry. Vol. IV. A Digest of Clinic Teachings 1902 and 1903.
Journal: JAMA (1905)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Imaging diagnosis of small hepatocellular carcinoma
Authors: K Ikeda
Journal: Hepatology (1994)

To elucidate the detectability of small hepatocellular carcinoma by various imaging modalities, we performed digital subtraction angiography, computed tomographic arterioportography and carbon dioxide-enhanced ultrasonography. Of 76 patients with a small hepatocellular carcinoma of 2 cm or less in maximum diameter, 61 underwent digital subtraction angiography, computed tomographic arterioportography and enhanced ultrasonography at the same time. Concerning the 61 patients undergoing all the procedures, the characteristics of hepatocellular carcinoma were found in 57.4% (35 of 61) by digital subtraction angiography, 75.4% (46 of 61) by computed tomographic arterioportography and 72.1% (44 of 61) by enhanced ultrasonography. Among them, four hepatocellular carcinomas were detected only by enhanced ultrasonography, three were diagnosed only by computed tomographic arterioportography and two were diagnosed by both of them. Except for six hemangioma nodules that were easily diagnosed only with angiography, four of 55 benign hepatic nodules (7.3%) showed false-positive findings suggestive of hepatocellular carcinoma with either computed tomographic arterioportography or enhanced ultrasonography. In conclusion, computed tomographic arterioportography and enhanced ultrasonography could complementarily detect a small hepatocellular carcinoma more sensitively than digital subtraction angiography.
白细胞介素-31和皮肌炎瘙痒
Authors: H.J. Kim, M. Zeidi, D. Bonciani, S.M. Pena, J. Tiao, S. Sahu, V.P. Werth
Journal: British Journal of Dermatology (2018)

皮肌炎患者通常会出现瘙痒,但是发病机理尚不清楚。本研究的作者来自美国、韩国和意大利开展,研究目的是查明皮肌炎患者出现瘙痒有多普遍以及受影响的皮肤中IL‐31细胞因子是否会增加。细胞因子是免疫系统中的细胞产生的蛋白质,细胞因子必须保持微妙平衡才能维持身体健康。而在某些皮肤病(比如异位性湿疹)患者体内,这种平衡被打破,产生了过多的促炎细胞因子(即导致炎症的细胞因子)。本研究调查了191名皮肌炎患者,作者采集了皮肤病变的活检样本,与四个健康对照样本(无皮肌炎之人)进行对比。他们发现半数患者存在中度至重度瘙痒,而瘙痒与疾病严重程度有关。在瘙痒皮肌炎患者的皮肤病变中,IL‐31及其受体的基因表达增加(即释放出更多IL‐31和帮助其发挥作用的受体),患者瘙痒越严重,这种表达越强烈。针对皮肌炎正在研究的一种新药lenabasum能够减少或“下调”IL‐31的表达,因此作者得出结论,该药可能在治疗皮肌炎瘙痒方面具有价值。
Clinical Reports.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Early discharge of newborns
Authors: A. F. Jerant
Journal: JAMA (1997)

<h3>To the Reply</h3> —Although we commend Dr Liu and colleagues<sup>1</sup>for attempting to address the complex and controversial issue of safety of early newborn discharge, we find their conclusions misleading and premature given the tenuousness of the data presented. First, although the authors claim that early discharge was associated with an increased risk of sepsis, their data do not clearly support this conclusion. Table 4 in their article lists an unadjusted OR for sepsis in early discharge infants of 1.53 (95% CI, 1.00-2.33), and the difference compared with infants discharged later did not reach statistical significance. The same concerns hold for their conclusions regarding dehydration risk (unadjusted OR, 1.28; 95% CI, 0.87-1.88). Second, the study design did not allow for a uniform definition of pathologic hyperbilirubinemia. It is likely that some infants admitted with this diagnosis had mild or physiologic jaundice that was managed in an inappropriately aggressive manner. Our teaching faculty
Effects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women
Journal: Journal of Clinical Investigation (1989)

The first line of the abstract should read, "Treatment of postmenopausal women with low doses of estradiol-1 7# (1 mg/d) and dl-norgestrel (0.075 mg/d) significantly reduced fasting serum levels of low density lipoprotein (LDL). . .."The second line of Methods should read "Each experienced typical menopausal symptoms and was amenorrheic for at least 6 mo (serum follicle-stimulating hormone > 70 U/liter) before starting hormonal replacement therapy with estradiol-1 7i (1 mg/d, 25 of 28 d) and dl-norgestrel (0.075 mg/d, 28 of 28 d) 4 yr earlier."
Phase 1 Study of Radiosensitization Using Bortezomib in Patients with Relapsed Non-Hodgkin's Lymphoma Receiving Radioimmunotherapy
Authors: Rebecca L. Elstrom, John P. Leonard, Paul Christos, Peter Martin, Daniel Lebovic, Joseph Osborne, Stanley J. Goldsmith, June Greenberg, Richard R. Furman, Jia Ruan, Ryan Putman, Erica Chapman, Madhu Mazumdar, Kent A. Griffith, Morton Coleman, Mark S. Kaminski
Journal: Blood (2012)
Neurologists study abnormal CSF, stroke associated with AIDS
Authors: M. F. Goldsmith
Journal: JAMA (1988)

STROKE IS 40 times more likely to occur in persons under 45 years of age who are infected with the human immunodeficiency virus (HIV) than in similarly aged noninfected persons, according to a report presented to the American Academy of Neurology. Speaking recently in Cincinnati at the group's 40th annual meeting, John Engstrom, MD, chief resident in neurology at the University of California, San Francisco, reported on a study of 1600 white male homosexuals with acquired immunodeficiency syndrome (AIDS) in which the frequency of stroke occurrence was 1%. The rate in the general population 35 to 45 years of age is 25 per 100000 (0.025%). Of 28 patients with severe neurological problems, Engstrom said, 13 had suffered cerebral infarction (stroke), 13 had transient neurological deficit, and two had both conditions. The youngest patient with stroke was 27 years old. Stroke was the initial manifestation of AIDS in nine of the
Highlights
Journal: JAMA (2016)

Management of acute respiratory distress syndrome (ARDS) is primarily supportive.Whether early intervention can prevent the development of ARDS is not known.In a multicenter randomized placebo-controlled trial that enrolled 400 patients who presented to the emergency department and were assessed to be at risk of developing ARDS, Kor and colleagues evaluated the effi cacy and safety of early aspirin administration for prevention of ARDS.The authors found that compared with placebo, use of aspirin-a 325-mg loading dose followed by 81 mg/d through hospital day 7-did not reduce the risk of ARDS at 7 days.An Editorial by Reilly and Christie discusses prevention of ARDS.
Highlights
Journal: JAMA (2015)

Mindfulness-Based Stress Reduction for PTSD in Veterans 456Experiential avoidance is a key factor in the development and maintenance of posttraumatic stress disorder (PTSD).Mindfulness-based interventions encourage nonjudgmental acceptance of thoughts, feelings, and experiences without avoidance.In a randomized trial that enrolled 116 veterans with PTSD, Polusny and colleagues compared mindfulnessbased stress reduction with present-centered group therapy for treatment of PTSD.The authors report that compared with present-centered group therapy, mindfulness-based stress reduction resulted in a greater decrease in self-reported PTSD symptom severity during treatment and at 2-month follow-up, with the magnitude of symptom improvement suggesting a modest therapeutic eff ect.In an Editorial, Kearney and Simpson discuss treatment of PTSD.
Unusual Case of Hodgkin's Disease Presenting the X-ray Appearance of Lung Abscess
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
BERLIN
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Potentiation of warfarin anticoagulation by acetaminophen
Authors: W. R. Bartle
Journal: JAMA (1991)

<h3>In Reply.—</h3> Schindler comments on two aspects of the rate of obese children developing major psychiatric problems during the 10-year follow-up reported by us. He questions whether obese children typically develop psychiatric problems by early adulthood at the rate observed. The study we completed was not designed to assess this question, and we are not aware of epidemiologic studies that have evaluated this risk. Schindler also questions whether the rate reported may have been due in part to the use of behavior modification treatments. While there are no data on negative sequelae of behavior modification treatment of obesity in children, the types of family-based behavior modification treatments used in this study are similar to those that have been developed and used successfully in treatment of child psychopathology, and thus do not seem likely to induce pathological effects. Research on dieting and depression in adults<sup>1</sup>does not suggest that behavior
Abortion and Unplanned Pregnancy
Authors: S. Eapen
Journal: JAMA (2000)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract 3281: PDX Finder: An open and global catalogue of patient tumor-derived xenograft models
Authors: Nathalie A. Conte, Terrence F. Meehan, Dale A. Begley, Debbie M. Krupke, Csaba Halmagyi, Jeremy C. Mason, Abayomi Mosaku, Steven B. Neuhauser, Helen Parkinson, Carol J. Bult
Journal: Cancer Research (2018)

Abstract Patient-derived tumor xenograft (PDX) mouse models have emerged as an important oncology research platform to study tumor evolution, drug response and for tailoring chemotherapeutic approaches to individual patients. PDX models are produced and made available in repositories managed by small academic labs, large research consortia and contract research organizations. Because of the distributed and heterogeneous nature of PDX repositories, finding relevant models of interest to investigators is a challenge. To address this issue, The Jackson Laboratory and EMBL-EBI have co-developed the PDX Finder, a comprehensive open global catalogue of PDX models and their associated data across resources. In support this initiative, we coordinated the community initiative to develop the PDX models Minimal Information standard (PDX-MI) that defines the minimal information necessary for describing key elements of a PDX model including the clinical attributes of a patient's tumor, methods of implantation, host strain, and quality assurance methods used for model validation†. PDX-MI serves as the basis for PDX Finder's comprehensive search and attribute filtering options (e.g., tumor histology, molecular variant, drug response). Within PDX Finder, model attributes are harmonized and integrated into a cohesive ontological data model that supports consistent searching across the originating resources. From PDX Finder, direct links to these resources are provided to allow users to contact the relevant institution for model acquisition and further collaboration. PDX Finder is formally collaborating with several worldwide consortia including PDXnet and EurOPDX to increase “findability” of PDX models and to advance cancer research and drug discovery. PDX Finder is currently displaying over 1200 PDX models for a wide variety of cancers and is actively recruiting more models. The community is invited to explore and provide feedback on our portal as we build this rich resource at : www.pdxfinder.org. † Meehan et al, 2017. PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models. Cancer Res. 2017 Nov 1;77(21):e62-e66. Citation Format: Nathalie A. Conte, Terrence F. Meehan, Dale A. Begley, Debbie M. Krupke, Csaba Halmagyi, Jeremy C. Mason, Abayomi Mosaku, Steven B. Neuhauser, Helen Parkinson, Carol J. Bult. PDX Finder: An open and global catalogue of patient tumor-derived xenograft models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 3281.
AN AGED ATHLETE.
Journal: JAMA (2006)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
LAW &amp;amp; MEDICINE
Authors: Joseph E. Simonaitis
Journal: JAMA (1973)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hitler
Journal: JAMA (1999)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Two new tests for chlamydia get quick results without culture
Authors: L. Wingerson
Journal: JAMA (1983)

Two simple new tests to detect<i>Chlamydia trachomatis</i>are springing onto the market virtually at once. They promise an end to an era when most physicians ignored the preponderant venereal disease-causing organism in the United States because there was no practical way to detect it. The microorganism survives only inside living cells, and the culture techniques for keeping it alive are technically demanding. One new test uses a special solution to break down cell walls of epithelial cells and employs antibodies that detect chlamydia group antigens on the surface of the exposed organisms or the extracellular elementary bodies—dead or alive— with techniques now routine in research laboratories. This enzyme-linked immunoassay, the first test to emerge, was devised by Abbott Laboratories, North Chicago, Ill, and is in limited distribution. Close on its heels is a competing method—just approved for marketing by the Food and Drug Administration—that detects the organism with a
Edoxaban (Savaysa)—The Fourth New Oral Anticoagulant
Journal: JAMA (2015)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal